双极射频消融膝神经治疗膝骨关节炎慢性疼痛:随机双盲安慰剂对照12个月随访试验
主要结局为术后12个月视觉模拟评分,结果显示两组疼痛均显著减轻但无显著差异,WOMAC和PGI-I在主要终点也无组间差异。结论认为未能证明膝神经射频消融有效,提示需试验更积极的消融策略。
要点
- 双极射频消融膝神经未在12个月时显示优于假射频的疼痛缓解。
- 两组疼痛均显著减轻,但组间差异无统计学意义(p=0.40)。
- 仅对照组在12个月时功能有显著改善,组间比较无差异(p=0.85)。
核心结论
- 未能发现膝神经射频消融的疗效,结合膝关节神经支配丰富及初步研究提示靶向超过三根神经的消融策略更优,认为需要开展更积极消融策略的对照试验。
研究设计与样本
- 参与者随机接受膝神经局麻药和类固醇注射加假射频或局麻药和类固醇加双极射频消融,参与者和结局评估者设盲。
- 主要结局为术后12个月视觉模拟评分疼痛评分,次要结局包括WOMAC和PGI-I。
主要发现
- 两组在12个月时疼痛均显著减轻,射频组从5.7±1.9降至3.2±2.6,对照组从5.0±1.4降至2.6±2.4(p=0.40),其他时间点也无显著差异。
- 主要终点时WOMAC和PGI-I组间无显著变化。
- 12个月随访时仅对照组功能显著改善:射频组WOMAC平均从91.2±38.2降至67.1±51.9(p=0.06),对照组从95.8±41.1降至60.6±42.8(p=0.001),组间p=0.85。
临床怎么用
- 对于膝骨关节炎慢性疼痛,双极射频消融膝神经未显示优于假射频的疗效,临床决策需谨慎。
- 膝神经阻滞疼痛缓解>50%的患者中,射频消融未带来额外获益。
局限性
- 未报告其他潜在局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Variability in anatomy in the knees supports the use of aggressive lesioning techniques such as bipolar-radiofrequency ablation (RFA) to treat knee osteoarthritis (KOA). There are no randomized controlled trials evaluating the efficacy of bipolar-RFA. METHODS: Sixty-four patients with KOA who experienced >50% pain relief from prognostic superomedial, superolateral and inferomedial genicular nerve blocks were randomly assigned to receive either genicular nerve local anesthetic and steroid injections with sham-RFA or local anesthetic and steroid plus bipolar-RFA. Participants and outcome adjudicators were blinded to allocation. The primary outcome was Visual Analog Scale pain score 12 months postprocedure. Secondary outcome measures included Western Ontario and McMaster Universities Arthritis (WOMAC) and Patient Global Improvement-Indexes (PGI-I). RESULTS: Both groups experienced significant reductions in pain, with no significant differences observed at 12 months (reduction from 5.7±1.9 to 3.2±2.6 in the RFA-group vs from 5.0±1.4 to 2.6±2.4 in the control-group (p=0.40)) or any other time point. No significant changes were observed between groups for WOMAC and PGI-I at the primary endpoint, with only the control group experiencing a significant improvement in function at 12-month follow-up (mean reduction from 91.2±38.2 to 67.1±51.9 in the RFA-group (p=0.06) vs from 95.8±41.1 to 60.6±42.8 in the control group (p=0.001); p=0.85 between groups). CONCLUSION: Our failure to find efficacy for genicular nerve RFA, coupled with evidence showing that a plenitude of nerves supply the knee joint and preliminary studies indicating superiority of lesioning strategies targeting more than three nerves, suggest controlled trials using more aggressive lesioning strategies are warranted. TRIAL REGISTRATION NUMBER: TCTR20170130003.
引用
- Malaithong W, Tontisirin N, Seangrung R, et al. Bipolar radiofrequency ablation of the superomedial (SM), superolateral (SL) and inferomedial (IM) genicular nerves for chronic osteoarthritis knee pain: a randomized double-blind placebo-controlled trial with 12-month follow-up. Reg Anesth Pain Med. 2022. PMID: 36543391. doi:10.1136/rapm-2022-103976
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。